CHFR Antibody

中文名稱：

CHFR兔多克隆抗體
貨號(hào)：

CSB-PA972040
規(guī)格：

￥2024
圖片：
Western blot analysis of extracts from Jurkat cells, using CHFR antibody.
其他：

產(chǎn)品詳情
產(chǎn)品評(píng)價(jià)
相關(guān)產(chǎn)品
靶點(diǎn)詳情

產(chǎn)品詳情

產(chǎn)品名稱：

Rabbit anti-Homo sapiens (Human) CHFR Polyclonal antibody
Uniprot No.：

Q96EP1
基因名：

CHFR
宿主：

Rabbit
反應(yīng)種屬：

Human,Mouse,Rat
免疫原：

Synthesized peptide derived from Internal of Human CHFR.
免疫原種屬：

Homo sapiens (Human)
克隆類型：

Polyclonal
純化方式：

The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
濃度：

It differs from different batches. Please contact us to confirm it.
產(chǎn)品提供形式：

Liquid
應(yīng)用范圍：

ELISA,WB

推薦稀釋比：

Application	Recommended Dilution
WB	1:500-1:3000

Protocols：

ELISA Protocol
Western Blotting (WB) Protocol
儲(chǔ)存條件：

Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
貨期：

Basically, we can dispatch the products out in 1-3 working days after receiving your orders. Delivery time maybe differs from different purchasing way or location, please kindly consult your local distributors for specific delivery time.
用途：

For Research Use Only. Not for use in diagnostic or therapeutic procedures.

產(chǎn)品評(píng)價(jià)

靶點(diǎn)詳情

功能：

E3 ubiquitin-protein ligase that functions in the antephase checkpoint by actively delaying passage into mitosis in response to microtubule poisons. Acts in early prophase before chromosome condensation, when the centrosome move apart from each other along the periphery of the nucleus. Probably involved in signaling the presence of mitotic stress caused by microtubule poisons by mediating the 'Lys-48'-linked ubiquitination of target proteins, leading to their degradation by the proteasome. Promotes the ubiquitination and subsequent degradation of AURKA and PLK1. Probably acts as a tumor suppressor, possibly by mediating the polyubiquitination of HDAC1, leading to its degradation. May also promote the formation of 'Lys-63'-linked polyubiquitin chains and functions with the specific ubiquitin-conjugating UBC13-MMS2 (UBE2N-UBE2V2) heterodimer. Substrates that are polyubiquitinated at 'Lys-63' are usually not targeted for degradation, but are rather involved in signaling cellular stress.
基因功能參考文獻(xiàn)：
1. JNK inhibitor prevents SIRT1 phosphorylation, leading to elevated SIRT1 protein levels even in the presence of H2O2. Taken together, our results indicate that CHFR plays a crucial role in the cellular stress response pathway by controlling the stability and function of SIRT1. PMID: 27883020
2. Re-expression of CHFR in miR-26a overexpressing cells partially rescues normal mitosis and impairs the tumorigenesis exerted by miR-26a. PMID: 28126920
3. Data show that hypermethylation of the CHFR promoter, frequent in acute myeloid leukemia, is associated with adverse outcome, and can thus be used for risk stratification. PMID: 26542416
4. Small molecule inhibition of CHFR-PARP1 interaction is a novel potential therapeutic approach to increase the efficacy of taxane-based chemotherapy in cancer. PMID: 26356822
5. CHFR unmethylation is associated with oxaliplatin resistance in gastric cancer. PMID: 24748501
6. CHFR methylation has a role in methylation of DNA damage repair and apoptotic pathway genes in non-small cell lung cancer PMID: 25828518
7. CHFR promoter methylation is associated with colorectal cancer. PMID: 24928946
8. CHFR-PAX5 fusion transcript is associated with B-cell precursor acute lymphoblastic leukemia. PMID: 25304615
9. Aberrant methylation of CHFR may be associated with the pathogenesis, progression for B-cell non-Hodgkin lymphoma(B-NHL), which might be a novel molecular marker as prognosis and treatment for B-NHL. PMID: 25798877
10. Studies indicate that checkpoint with forkhead and ring finger domains (CHFR) promoter CpG island methylation as prognostic marker. PMID: 24375389
11. CHFR ubiquitinates and regulates TOPK levels, which is essential for its checkpoint function. PMID: 24012691
12. CHFR methylation may have a role in chemosensitivity of paclitaxel in advanced gastric cancer PMID: 24639283
13. CHFR methylation in CRC cell lines predicted for sensitivity in vitro and in vivo to docetaxel, while MSI-H cell lines were more sensitive to gemcitabine PMID: 23873170
14. CHFR expression is a novel predictive marker of response and overall survival in NSCLC patients treated with taxane-containing chemotherapy PMID: 23386692
15. CHFR aberrant methylation involves a subset of human lung adenocarcinoma associated with poor clinical outcomes. PMID: 23415374
16. a new regulatory mechanism for CHFR that sequential post-translational modifications of CHFR by SUMO and ubiquitin coordinately regulates its stability PMID: 23454125
17. this study underscores the importance of CHFR SUMOylation as a new regulatory mechanism of CHFR and highlights the emerging role of SUMOylation in modulating protein stability. PMID: 23131550
18. Aggregated LDL prolongs the half life of LRP1 by preventing the receptor ubiquitinylation, at least in part, through CHFR targeting. PMID: 23241409
19. suppression of CHFR induced a significant increase of the mitotic index and much lower numbers of cells at the G2/M phase in both cells treated with taxol, indicating mitotic checkpoint impairment PMID: 22469813
20. CHFR is thought to contribute towards regulating mitotic entry and possible explanations for contradictory observations published on the functions and regulation of CHFR are presented. [review] PMID: 22159584
21. The interaction between CHFR and PARP-1 plays an important role in cell cycle regulation and cancer therapeutic strategies. PMID: 22337872
22. CHFR is epigenetically inactivated by promoter methylation in nasopharyngeal carcinoma. PMID: 22070084
23. Hypermethylation of CHFR gene is associated with advanced gastric cancer. PMID: 21409489
24. Aberrant methylation of the CHFR gene is a frequent event in the carcinogenesis of gastric cancer. PMID: 20109344
25. The extent of CHFR promoter methylation correlates with RFS, indicating it is a promising epigenetic marker for recurrence. PMID: 21551253
26. auto-ubiquitylation of E3 ubiquitin-protein ligase Chfr at G2 phase is required for accumulation of polo-like kinase 1 and mitotic entry in mammalian cell PMID: 21768102
27. Aberrant promoter methylation of Runx3 and CHFR genes may be involved in the carcinogenesis and development of gastric cancer PMID: 20300977
28. Hypermethylation of CHFR gene promoter is associated with loss or lower expression of CHFR mRNA in laryngeal squamous cell carcinoma. PMID: 20942233
29. These data support a critical role for CHFR in the MAD2 spindle checkpoint. PMID: 21575600
30. CHFR methylation in cancer tissues was significantly associated with the extent of differentiation and lymph node metastasis of gastric cancer. PMID: 21302620
31. results demonstrate that CHFR loss might be critical for the tumorigenesis of NSCLC in patients with a history of smoking and induces tumors of a more malignant phenotype than the EGFR mutation PMID: 20473935
32. The PBZ motif of CHFR recognizes two adenine-containing subunits of PAR and the phosphate backbone that connects them PMID: 20880844
33. Taken together, their findings demonstrated that both epigenetic and genetic mechanisms were involved in silencing CHFR expression in EACs. PMID: 20564104
34. The Chfr-TCTP interaction was stable throughout the cell cycle, but it could be diminished by the complete depolymerization of the microtubules. PMID: 18504434
35. this is the first report identifying the regulatory mechanism of HLTF by CHFR, suggesting that CHFR-mediated downregulation of HLTF may help protect against cancer. PMID: 20388495
36. Gene methylation (CHFR, E-cadherin, BNIP3) in the peritoneal fluid could detect occult neoplastic cells in the peritoneum and might be a risk factor for peritoneal metastasis. PMID: 20082478
37. checkpoint protein Chfr is a ligase that ubiquitinates Plk1 and inhibits Cdc2 at the G2 to M transition PMID: 11807090
38. Chfr regulates a mitotic stress pathway through its RING-finger domain with ubiquitin ligase activity. PMID: 11912157
39. expression is downregulated by CpG island hypermethylation in esophageal cancer PMID: 12376479
40. Frequent hypermethylation of the 5' CpG island of the mitotic stress checkpoint gene Chfr in colorectal and non-small cell lung cancer. PMID: 12538348
41. CHFR has a role in mitotic checkpoint control PMID: 12810945
42. Chfr may have a role in signaling the presence of mitotic stress induced by microtubule poisons PMID: 14562038
43. That the chfr gene is frequently silenced in various tumors because of methylation of its promoter, these findings suggest that chfr is inactivated by multiple mechanisms in human cancer. PMID: 14612512
44. Chfr is frequently inactivated in colon but not breast cancers, through a mechanism of hypermethylation of the promoter sequences. PMID: 14654793
45. Aberrant promoter methylation of the CHFR gene was observed in a significant proportion of human gastric cancers. PMID: 15201973
46. CHFR has a role in blocking mitosis along with p38 MAP kinase PMID: 15302856
47. PML bodies control the distribution, dynamics and function of CHFR PMID: 15467728
48. We conclude that the mechanism by which CHFR delays chromosome condensation involves inhibition of accumulation of Cyclin B1 in the nucleus. PMID: 15674323
49. The loss of checkpoint control associated with methylation of CHFR suggests the potential to overcome cell cycle checkpoints, which may lead to an accumulation of mutations. PMID: 15760919
50. downregulation of CHFR is a common event in nasopharyngeal carcinoma cells which may be due to hypermethylation of the gene promoter region PMID: 15937956
顯示更多

收起更多
亞細(xì)胞定位：

Nucleus, PML body.
蛋白家族：

CHFR family
組織特異性：

Ubiquitous.
數(shù)據(jù)庫(kù)鏈接：

HGNC: 20455

OMIM: 605209

KEGG: hsa:55743

STRING: 9606.ENSP00000392395

UniGene: Hs.720197

Most popular with customers

YWHAG Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC

Species Reactivity: Human
YWHAB Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC, IF, FC

Species Reactivity: Human, Mouse, Rat
Phospho-YAP1 (S127) Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC

Species Reactivity: Human
XRCC5 Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC, IF

Species Reactivity: Human
XDH Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC

Species Reactivity: Human
WFDC2 Recombinant Monoclonal Antibody

Applications: ELISA, WB, FC

Species Reactivity: Human
WDR5 Recombinant Monoclonal Antibody

Applications: ELISA, IHC, FC

Species Reactivity: Human
VDR Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC

Species Reactivity: Human